Humacyte, Inc. (HUMA)
0.9605
-0.05
(-4.90%)
USD |
NASDAQ |
Dec 31, 16:00
0.99
+0.03
(+3.07%)
After-Hours: 20:00
Humacyte Cash from Investing (Quarterly): -0.049M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CorMedix, Inc. | -291.32M |
| Rockwell Medical, Inc. | -4.309M |
| Nuwellis, Inc. | -0.098M |
| Salarius Pharmaceuticals, Inc. | -0.20M |
| Biomea Fusion, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.90M |
| Cash from Financing (Quarterly) | -44.59M |
| Free Cash Flow | -106.40M |
| Free Cash Flow Per Share (Quarterly) | -0.1513 |
| Free Cash Flow to Equity (Quarterly) | 9.14M |
| Free Cash Flow to Firm (Quarterly) | -21.34M |
| Free Cash Flow Yield | -77.40% |